Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Iterum Therapeutics Plc (NASDAQ: ITRM) was $0.39 for the day, up 4.38% from the previous closing price of $0.37. In other words, the price has increased by $4.38 from its previous closing price. On the day, 0.83 million shares were traded. ITRM stock price reached its highest trading level at $0.41 during the session, while it also had its lowest trading level at $0.3804.
Ratios:
Our analysis of ITRM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.96 and its Current Ratio is at 2.13.
On March 15, 2021, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $2.50.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on June 02, 2020, whereas the target price for the stock was revised from $7 to $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 18 ’25 when Dunne Michael W. bought 6,000 shares for $0.37 per share. The transaction valued at 2,191 led to the insider holds 241,001 shares of the business.
Dunne Michael W. bought 15,000 shares of ITRM for $10,854 on Aug 08 ’25. The Director now owns 235,001 shares after completing the transaction at $0.72 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ITRM now has a Market Capitalization of 18557356 and an Enterprise Value of 43119600. For the stock, the TTM Price-to-Sale (P/S) ratio is 52.28. Its current Enterprise Value per Revenue stands at 110.563 whereas that against EBITDA is -2.231.
Stock Price History:
The Beta on a monthly basis for ITRM is 3.01, which has changed by -0.80603015 over the last 52 weeks, in comparison to a change of 0.1028198 over the same period for the S&P500. Over the past 52 weeks, ITRM has reached a high of $3.02, while it has fallen to a 52-week low of $0.36. The 50-Day Moving Average of the stock is -40.42%, while the 200-Day Moving Average is calculated to be -59.13%.
Shares Statistics:
ITRM traded an average of 931.21K shares per day over the past three months and 1722480 shares per day over the past ten days. A total of 52.79M shares are outstanding, with a floating share count of 52.33M. Insiders hold about 0.86% of the company’s shares, while institutions hold 2.52% stake in the company. Shares short for ITRM as of 1761868800 were 1352384 with a Short Ratio of 1.45, compared to 1759190400 on 1271626. Therefore, it implies a Short% of Shares Outstanding of 1352384 and a Short% of Float of 2.8399997999999997.
Earnings Estimates
Its stock is currently analyzed by 1.0 different market analysts. The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.59 and -$0.59 for the fiscal current year, implying an average EPS of -$0.59. EPS for the following year is -$0.14, with 2.0 analysts recommending between $0.1 and -$0.38.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $1.4M. There is a high estimate of $1.4M for the next quarter, whereas the lowest estimate is $1.4M. Based on 2 analysts’ estimates, the company’s revenue will be $11.93M in the next fiscal year. The high estimate is $15.1M and the low estimate is $8.75M.
